Back to Scanner
RLMD
NASDAQRS 1Score 32Relmada Therapeutics, Inc.
HealthcareBiotechnology$512.60M2 setups passing
$6.99
-3.0% ($0.21)
-6.9% from 52W High
P/E (TTM)
-8.30
Fwd P/E
—
PEG
—
Analyst Upside
+28.8%
EPS Growth
—
Gross Margin
0.0%
ROE
-170.8%
D/E
—
Div Yield
0.0%
Avg Volume
1.8M
Price Chart
Key Levels
SMA 200
$2.89
SMA 50
$4.93
Price
$6.99
52W High
$7.51
Target
$9.00
Setup Radar
2/8 passing📈
CAN SLIMO'Neil
Near highs + RS ≥ 80
🎯
VCPMinervini
Within 25% high, RS ≥ 70, > 200 SMA
📊
Trend TemplateMinervini
> 50 & 200 SMA, RS ≥ 70, near high
🚀
Stage 2Weinstein
RS ≥ 60, > 200 SMA
📦
Darvas BoxDarvas
Near highs, > 200 SMA
⚡
Earnings MomentumGrowth
EPS growth ≥ 20%
🔍
PEG HunterLynch
PEG < 1.5, EPS growth ≥ 15%
🎪
Analyst UpsideConsensus
Target upside ≥ 15%, 1+ analyst